The history of the pharmacology and cloning of ionotropic glutamate receptors and the development of idiosyncratic nomenclature

Neuropharmacology

Volumn 56, Issue 1, 2009, Pages 6-21

  Lodge, David ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

AMPA receptors; History; Ionotropic glutamate receptors; Kainate receptors; NMDA receptors; Nomenclature

Indexed keywords

1 (4 AMINOPHENYL) 4 METHYL 7,8 METHYLENEDIOXY 5H 2,3 BENZODIAZEPINE; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; 6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; AMPA RECEPTOR; AMPA RECEPTOR ANTAGONIST; ASPARTIC ACID; BENZODIAZEPINE; BICUCULLINE; BINDING PROTEIN; CONCANAVALIN A; CYCLOTHIAZIDE; DEXTRO 2 AMINOADIPIC ACID; DIZOCILPINE; DOMOIC ACID; GLUTAMATE BINDING PROTEIN; GLUTAMATE RECEPTOR; GLUTAMIC ACID; IFENPRODIL; IONOTROPIC RECEPTOR; KAINIC ACID; KAINIC ACID RECEPTOR; KAINIC ACID RECEPTOR ANTAGONIST; KETAMINE; KYNURENIC ACID; MAGNESIUM; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROPEPTIDE Y; PHENCYCLIDINE; SOMATOSTATIN; STRYCHNINE; UNCLASSIFIED DRUG;

CHROMOSOMAL LOCALIZATION; DEPOLARIZATION; DEPRESSION; DRUG BINDING SITE; EXCITATORY POSTSYNAPTIC POTENTIAL; HIPPOCAMPUS; HISTORY; HUMAN; LEARNING; LONG TERM POTENTIATION; MOLECULAR CLONING; NERVE CELL PLASTICITY; NERVE CELL STIMULATION; NEUROPHARMACOLOGY; NEUROPROTECTION; NOCICEPTION; NOMENCLATURE; NONHUMAN; PRIORITY JOURNAL; PURKINJE CELL; RECEPTOR DOWN REGULATION; RENSHAW CELL; REVIEW; SYNAPTIC TRANSMISSION;

ANIMALS; CLONING, MOLECULAR; GLUTAMIC ACID; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; RECEPTORS, GLUTAMATE; TERMINOLOGY AS TOPIC;

EID: 58049103433     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2008.08.006     Document Type: Review

References (276)

1. Agrawal S.G., and Evans R.H. The primary afferent depolarizing action of kainate in the rat. British Journal of Pharmacology 87 (1986) 345-355
2. Andreasen M., Lambert J.D., and Jensen M.S. Direct demonstration of an N-methyl-d-aspartate receptor mediated component of excitatory synaptic transmission in area CA1 of the rat hippocampus. Neuroscience Letters 93 (1988) 61-66
3. Andreasen M., Lambert J.D., and Jensen M.S. Effects of new non-N-methyl-d-aspartate antagonists on synaptic transmission in the in vitro rat hippocampus. Journal of Physiology 414 (1989) 317-336
4. Anis N.A., Berry S.C., Burton N.R., and Lodge D. The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurons by N-methyl-d-aspartate. British Journal of Pharmacology 79 (1983) 565-575
5. Arai A.C., Kessler M., Rogers G., and Lynch G. Effects of the potent ampakine CX614 on hippocampal and recombinant AMPA receptors: interactions with cyclothiazide and GYKI 52466. Molecular Pharmacology 58 (2000) 802-813
6. Araki K., Meguro H., Kushiya E., Takayama C., Inoue Y., and Mishina M. Selective expression of the glutamate receptor channel delta 2 subunit in cerebellar Purkinje cells. Biochemical and Biophysical Research Communications 197 (1993) 1267-1276
7. Ault B., Evans R.H., Francis A.A., Oakes D.J., and Watkins J.C. Selective depression of excitatory amino acid-induced depolarizations by magnesium in isolated spinal cord preparations. Journal of Physiology 307 (1980) 413-428
8. Balcar V.J., and Johnston G.A.R. The structural specificity of the high affinity uptake of l-glutamate and l-aspartate by rat brain slices. Journal of Neurochemistry 19 (1972) 2657-2666
9. Balannik V., Menniti F.S., Paternain A.V., Lerma J., and Stern-Bach Y. Molecular mechanism of AMPA receptor noncompetitive antagonism. Neuron 48 (2005) 279-288
10. Bashir Z.I., Alford S., Davies S.N., Randall A.D., and Collingridge G.L. Long-term potentiation of NMDA receptor-mediated synaptic transmission in the hippocampus. Nature 349 (1991) 156-158
11. Baudry M., Kramer K., Fagni L., Recasens M., and Lynch G. Classification and properties of acidic amino acid receptors in hippocampus. II. Biochemical studies using a sodium efflux assay. Molecular Pharmacology 24 (1983) 222-228
12. Beal M.F., Kowall N.W., Swartz K.J., Ferrante R.J., and Martin J.B. Differential sparing of somatostatin-neuropeptide Y and cholinergic neurons following striatal excitotoxin lesions. Synapse 3 (1989) 38-47
13. Berl S., and Waelsch H. Determination of glutamic acid, glutamine, glutathione and gamma-aminobutyric acid and their distribution in brain tissue. Journal of Neurochemistry 3 (1958) 161-169
14. Berman R.M., Cappiello A., Anand A., Oren D.A., Heninger G.R., Charney D.S., and Krystal J.H. Antidepressant effects of ketamine in depressed patients. Biological Psychiatry 47 (2000) 351-354
15. Bertolino M., Baraldi M., Parenti C., Braghiroli D., DiBella M., Vicini S., and Costa E. Modulation of AMPA/kainate receptors by analogues of diazoxide and cyclothiazide in thin slices of rat hippocampus. Receptors and Channels 1 (1993) 267-278
16. Bettler B., Boulter J., Hermans-Borgmeyer I., O'Shea-Greenfield A., Deneris E.S., Moll C., Borgmeyer U., Hollmann M., and Heinemann S. Cloning of a novel glutamate receptor subunit, GluR5: expression in the central nervous system during development. Neuron 5 (1990) 583-595
17. Bettler B., Egebjerg J., Sharma G., Pecht G., Herman-Borgmeyer I., Moll C., Stevens C.F., and Heinemannn S. Cloning of a putative glutamate receptor: a low affinity kainate binding subunit. Neuron 8 (1992) 257-265
18. Birch P.J., Grossman C.J., and Hayes A.G. Kynurenic acid antagonises responses to NMDA via an action at the strychnine-insensitive glycine receptor. European Journal of Pharmacology 154 (1988) 85-87
19. Biscoe T.J., Davies J., Dray A., Evans R.H., Francis A.A., Martin M.R., and Watkins J.C. Depression of synaptic excitation and of amino acid-induced excitatory responses of spinal neurones by d-α-aminoadipate, α,ε-diaminopimelic acid and HA-966. European Journal of Pharmacology 45 (1977) 315-316
20. Biscoe T.J., Evans R.H., Headley P.M., Martin M.R., and Watkins J.C. Domoic and quisqualic acids as potent amino acid excitants of frog and rat spinal neurons. Nature 8 (1975) 166-167
21. Biscoe T.J., Evans R.H., Headley P.M., Martin M.R., and Watkins J.C. Structure-activity relations of excitatory amino acids on frog and rat spinal neurons. British Journal of Pharmacology 58 (1976) 373-382
22. Biziere K., and Coyle J.T. Effects of cortical ablation on the neurotoxicity and receptor binding of kainic acid in striatum. Journal of Neuroscience Research 4 (1979) 383-398
23. Blake J.F., Brown M.W., and Collingridge G.L. CNQX blocks acidic amino acid induced depolarizations and synaptic components mediated by non-NMDA receptors in rat hippocampal slices. Neuroscience Letters 89 (1988) 182-186
24. Bleakman D., Ballyk B.A., Schoepp D.D., Palmer A.J., Bath C.P., Sharpe E.F., Wooley M.L., Bufton H.W., Kamboj R.K., Tarnawa I., and Lodge D. Activity of 2,3-benzodiazepines at native rat and recombinant human glutamate receptors in vitro: stereospecificity and selectivity profiles. Neuropharmacology 35 (1996) 1689-1702
25. Bleakman D., and Lodge D. Neuropharmacology of AMPA and kainate receptors. Neuropharmacology 37 (1998) 1187-1204
26. Bliss T.V.P., and Collingridge G.L. A synaptic model of memory: long term potentiation in the hippocampus. Nature 361 (1993) 31-39
27. Bortolotto Z.A., Clarke V.J., Smolders I., Delany C.M., Parry M.C., Vignes M., Hoo K.H., Ogden A., Gates M., Ornstein P.L., Lodge D., Bleakman D., and Collingridge G.L. Kainate receptors are involved in synaptic plasticity. Nature 402 (1999) 297-301
28. Boulter J., Hollmann M., O'Shea-Greenfield A., Hartley M., Deneris Maron C., and Heinemann S. Molecular cloning and functional expression of glutamate receptor subunit genes. Science 249 (1990) 1033-1037
29. Bradford H.F., and Ward H.K. On glutaminase activity in mammalian synaptosomes. Brain Research 110 (1976) 115-125
30. Brorson J.R., Bleakman D., Chard P.S., and Miller R.J. Calcium directly permeates kainate AMPA receptors in cultured cerebellar Purkinje neurons. Molecular Pharmacology 41 (1992) 603-608
31. Campbell-Fleming J.M., and Williams A. The use of ketamine as adjuvant therapy to control severe pain. Clinical Journal of Oncology Nursing 12 (2008) 102-107
32. Carlsson A., Waters N., Holm-Waters S., Tedroff J., Nilsson M., and Carlsson M.L. Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence. Annual Review of Pharmacology and Toxicology 41 (2001) 237-260
33. Castillo P.E., Malenka R.C., and Nicoll R.A. Kainate receptors mediate a slow postsynaptic current in hippocampal CA3 neurons. Nature 388 (1997) 182-186
34. Chittajallu R., Vignes M., Dev K.K., Barnes J., Collingridge G.L., and Henley J.M. Regulation of glutamate release by presynaptic kainate receptors in the hippocampus. Nature 379 (1996) 780-781
35. Ciabarra A.M., Sullivan J.M., Gahn L.G., Pecht G., Heinemann S., and Sevarino K.A. Cloning and characterization of chi-1: a developmentally regulated member of a novel class of the ionotropic glutamate receptor family. Journal of Neuroscience 1 (1995) 6498-6508
36. Clark K.A., and Collingridge G.L. Synaptic potentiation of dual-component excitatory postsynaptic currents in the rat hippocampus. Journal of Physiology 482 (1995) 39-52
37. Clarke V.R., Ballyk B.A., Hoo K.H., Mandelyzys A., Pellizzari A., Bath C.P., Thomas J., Sharpe E.F., Davies C.H., Ornstein P.L., Schoepp D.D., Kamboj R.K., Collingridge G.L., Lodge D., and Bleakman D. A hippocampal GluR5 kainate receptor regulating inhibitory synaptic transmission. Nature 389 (1997) 599-603
38. Collingridge G.L., Kehl S.J., and McLennan H. Excitatory amino acids in synaptic transmission in the Schaffer collateral-commissural pathway of the rat hippocampus. Journal of Physiology 334 (1983) 33-46
39. Collingridge G.L., Herron C.E., and Lester R.A. Synaptic activation of N-methyl-d-aspartate receptors in the Schaffer collateral-commissural pathway of rat hippocampus. Journal of Physiology 399 (1988) 283-300
40. Collingridge G.L., and Lester R.A.S. Excitatory amino acid receptors in the vertebrate nervous system. Pharmacological Reviews 40 (1989) 145-195
41. Collingridge G.L., Olsen R.W., Peters J., and Spedding M. A nomenclature for ligand-gated ion channels. Neuropharmacology 56 (2009) 2-5
42. Croucher M.J., Collins J.F., and Meldrum B.S. Anticonvulsant action of excitatory amino acid antagonists. Science 216 (1982) 899-901
43. Crunelli V., Forda S., and Kelly J.S. The reversal potential of excitatory amino acid action on granule cells of the rat dentate gyrus. Journal of Physiology 351 (1984) 327-342
44. Cull-Candy S.G., and Usowicz M.M. Multiple-conductance channels activated by excitatory amino acids in cerebellar neurons. Nature 325 (1987) 525-528
45. Curtis D.R. The pharmacology of central and peripheral inhibition. Pharmacological Reviews 15 (1963) 333-363
46. Curtis D.R., and Eccles R.M. The excitation of Renshaw cells by pharmacological agents applied electrophoretically. Journal of Physiology 141 (1958) 435-445
47. Curtis D.R., and Johnston G.A.R. Amino acid transmitters in the mammalian central nervous system. Ergebnisse der Physiologie, Biologischen Chemie und Experimentellen Pharmakologie 69 (1974) 97-188
48. Curtis D.R., Johnston G.A.R., Game C.J.A., and McCulloch R.M. Antagonism of neuronal excitations by 1-hydroxy-3-amino-pyrrolidone-2. Brain Research 49 (1973) 467-470
49. Curtis D.R., Phillis J.W., and Watkins J.C. Chemical excitation of spinal neurons. Nature 183 (1959) 161-163
50. Curtis D.R., Phillis J.W., and Watkins J.C. The chemical excitation of spinal neurons by certain acidic amino acids. Journal of Physiology 150 (1960) 656-682
51. Curtis D.R., Phillis J.W., and Watkins J.C. Cholinergic and non-cholinergic transmission in the spinal cord. Journal of Physiology 150 (1961) 296-323
52. Curtis D.R., and Watkins J.C. The excitation and depression of spinal neurones by structurally related amino acids. Journal of Neurochemistry 6 (1960) 117-141
53. Curtis D.R., and Watkins J.C. Acidic amino acids with strong excitatory actions on mammalian neurones. Journal of Physiology 166 (1963) 1-14
54. Dale H.H. Transmission of Effects from Nerve Endings (1952), Oxford University Press, London
55. Dale N., and Roberts A. Dual-component amino-acid-mediated synaptic potentials: excitatory drive for swimming in Xenopus embryos. Journal of Physiology 363 (1985) 35-59
56. Dargan S.L., Clarke V.R.J., Alushin G.M., Sherwood J.L., Nistico R., Bortolotto Z.A., Doherty A., Lodge D., Mayer M.L., Fitzjohn S.M., Jane D.E., and Collingridge G.L. ACET is a highly potent and specific kainate receptor antagonist: Characterisation and effects on hippocampal mossy fibre function. Neuropharmacology 56 (2009) 121-130
57. Davies J., and Watkins J.C. Microelectrophoretic studies on the depressant action of HA-966 on chemically and synaptically-excited neurons in the cat cerebral cortex and cuneate nucleus. Brain Research 59 (1973) 311-322
58. Davies J., and Watkins J.C. Selective antagonism of amino acid-induced and synaptic events in the cat spinal cord. Journal of Physiology 297 (1979) 621-636
59. Davies J., and Watkins J.C. Actions of d and l forms of 2-amino-5-phosphonovalerate (d-AP5) and 2-amino-4-phosphonobutyrate in the cat spinal cord. Brain Research 235 (1982) 378-386
60. Davies J., and Watkins J.C. Depressant actions of γ-d-glutamylaminomethyl sulfonate (GAMS) on amino acid-induced and synaptic excitation in the cat spinal cord. Brain Research 327 (1985) 113-120
61. Davies J., and Watkins J.C. Differentiation of kainate and quisqualate receptors in the cat spinal cord by selective antagonism with gamma-d and l-glutamylglycine. Brain Research 206 (1981) 172-177
62. Davies L.P., and Johnston G.A.R. Uptake and release of d- and l-aspartate by rat brain slices. Journal of Neurochemistry 26 (1976) 1007-1014
63. Davies S.N., and Collingridge G.L. Role of excitatory amino acid receptors in synaptic transmission in area CA1 of rat hippocampus. Proceedings of the Royal Society of London, Series B 236 (1989) 373-384
64. Davies S.N., Lester R.A., Reymann K.G., and Collingridge G.L. Temporally distinct pre- and post-synaptic mechanisms maintain long-term potentiation. Nature 338 (1989) 500-503
65. Davies S.N., and Lodge D. Evidence for involvement of N-methylaspartate receptors in 'wind-up' of class 2 neurones in the dorsal horn of the rat. Brain Research 424 (1987) 402-406
66. Del Castillo J., and Katz B. On the localization of acetylcholine receptors. Journal of Physiology 128 (1955) 157-181
67. Dickenson A.H. A cure for wind up: NMDA receptor antagonists as potential analgesics. Trends in Pharmacological Sciences 11 (1990) 307-309
68. Do K.Q., Herrling P.L., Streit P., Turski W.A., and Cuenod M. In vitro release and electrophysiological effects in situ of homocysteic acid, an endogenous N-methyl-d-aspartic acid agonist, in the mammalian striatum. Journal of Neuroscience 6 (1986) 2226-2234
69. Domino E.F., Chodoff P., and Corssen G. Pharmacological effects of CI-581, a new dissociative anesthetic in man. Clinical Pharmacology and Therapeutics 6 (1965) 279-291
70. Domino E.F., and Luby E.D. Abnormal mental states induced by phencyclidine as a model of schizophrenia. In: Domino E.F. (Ed). PCP Phencyclidine. Historical and Current Perspectives (1981), NPP Books, Ann Arbor 401-413
71. Donevan S.D., and Rogawski M.A. GYKI 52466, a 2,3-benzodiazepine, is a highly selective, noncompetitive antagonist of AMPA/kainate receptor responses. Neuron 10 (1993) 51-59
72. Drejer J., Sheardown M., Nielsen E.O., and Honoré T. Glycine reverses the effect of HA-966 on NMDA responses in cultured rat cortical neurons and in chick retina. Neuroscience Letters 98 (1989) 333-338
73. Duggan A.W. The differential sensitivity to l-glutamate and l-aspartate of spinal interneurones and Renshaw cells. Experimental Brain Research 19 (1974) 522-528
74. Duggan A.W., and Johnston G.A.R. Glutamate and related amino acids in cat spinal roots, dorsal root ganglia and peripheral nerves. Journal of Neurochemistry 17 (1970) 1205-1208
75. Ebert B., Wong E.H., and Krogsgaard-Larsen P. Identification of a novel NMDA receptor in rat cerebellum. European Journal of Pharmacology 208 (1991) 49-52
76. Eccles J.C. The Physiology of Synapses (1964), Springer-Verlag, Berlin
77. Eccles J.C., and Jaeger J.C. The relationship between the mode of operation and the dimensions of the junctional regions at synapses and the motor end-organs. Proceedings of the Royal Society, Series B 148 (1957) 38-56
78. Egebjerg J., Bettler B., Hermans-Borgmeyer I., and Heinemann S. Cloning of a cDNA for a glutamate receptor activated by kainate but not AMPA. Nature 351 (1991) 745-748
79. Evans R.H., Francis A.A., Jones A.W., Smith D.A.S., and Watkins J.C. The effects of a series of ω-phosphonic α-carboxylic amino acids on electrically evoked and amino acid induced responses in isolated spinal cord preparations. British Journal of Pharmacology 75 (1982) 65-75
80. 2+ of amino acid-induced depolarization of spinal neurones. Experientia 33 (1977) 489-491
81. Fagg G.E., and Matus A. Selective association of N-methyl aspartate and quisqualate types of l-glutamate receptor with brain postsynaptic densities. Proceedings of the National Academy of Sciences of the United States of America 81 (1984) 6876-6880
82. Fagg G.E., Foster A.C., and Ganong A.H. Excitatory amino acid synaptic mechanisms and neurological function. Trends in Pharmacological Sciences 7 (1986) 357-363
83. Fagni L., Baudry M., and Lynch G. Classification and properties of acidic amino acid receptors in hippocampus. I. Electrophysiological studies of an apparent desensitization and interactions with drugs which block transmission. Journal of Neuroscience 3 (1983) 1538-1546
84. Fletcher E.J., and Lodge D. Glycine reverses antagonism of N-methyl-d-aspartate (NMDA) by 1-hydroxy-3-aminopyrrolidone-2 (HA-966) but not by d-2-amino-5-phophonovalerate (d-AP5) on rat cortical slices. European Journal of Pharmacology 151 (1988) 161-162
85. Fletcher E.J., Martin D., Aram J.A., Lodge D., and Honore T. Quinoxalinediones selectively block quisqualate and kainate receptors and synaptic events in rat neocortex and hippocampus and frog spinal cord in vitro. British Journal of Pharmacology 95 (1988) 585-597
86. Forsythe I.D., and Westbrook G.L. Slow excitatory postsynaptic currents mediated by N-methyl-d-aspartate receptors on cultured mouse central neurones. Journal of Physiology 396 (1988) 515-533
87. Foster A.C., and Fagg G.E. Acidic amino acid binding sites in mammalian membranes: their characteristics and relationship to synaptic receptors. Brain Research Reviews 7 (1984) 103-164
88. Foster A.C., and Fagg G.E. Acidic amino acid receptor nomenclature: time for change. Trends in Neurosciences 11 (1988) 17-18
89. Foster A.C., and Kemp J.A. HA-966 antagonizes N-methyl-d-aspartate receptors through a selective interaction with the glycine modulatory site. Journal of Neuroscience 9 (1989) 2191-2196
90. Frerking M., Malenka R.C., and Nicoll R.A. Synaptic activation of kainate receptors on hippocampal interneurons. Nature Neuroscience 1 (1998) 479-486
91. Graham Jr. L.T., Shank R.P., Werman R., and Aprison M.H. Distribution of some synaptic transmitter suspects in cat spinal cord: glutamic acid, aspartic acid, gamma-aminobutyric acid, glycine and glutamine. Journal of Neurochemistry 14 (1967) 465-472
92. Gregor P., Mano I., Maoz I., McKeown M., and Teichberg V.I. Molecular structure of the chick cerebellar kainate-binding subunit of a putative glutamate receptor. Nature 342 (1989) 689-692
93. Gunderson C.B., Miledi R., and Parker I. Messenger RNA from human brain induces drug- and voltage-operated channels in Xenopus oocytes. Nature 4 (1984) 421-424
94. Haldeman S., and McLennan H. The antagonistic action of glutamic acid diethylester towards amino acid-induced and synaptic excitations of central neurones. Brain Research 45 (1972) 393-400
95. Hamberger A., Chiang G., Nylén E.S., Scheff S.W., and Cotman C.W. Stimulus evoked increase in the biosynthesis of the putative neurotransmitter glutamate in the hippocampus. Brain Research 143 (1978) 549-555
96. Hampson D., Huie D., and Wenthold R.J. Solubilization of kainic acid binding sites from rat brain. Journal of Neurochemistry 56 (1987) 702-705
97. van Harreveld A. Compounds in brain extracts causing spreading depression of cerebral cortical activity and contraction of crustacean muscle. Journal of Neurochemistry 3 (1959) 300-315
98. Hayashi T. A physiological study of the epileptic seizures following cortical stimulation in animals and its application to human clinics. Japanese Journal of Physiology 3 (1952) 46-64
99. Hayashi T. Effects of sodium glutamate on the nervous system. Keio Journal of Medicine 3 (1954) 183-192
100. Henley J.M., Ambrosini A., Rodriguez-Ithurralde D., Sudan H., Brackley P., Kerry C., Mellor I., Abutidze K., Usherwood P.N., and Barnard E.A. Purified unitary kainatealpha-amino-3-hydroxy-5-methylisooxazole-propionate (AMPA) and kainate/AMPA/N-methyl-d-aspartate receptors with interchangeable subunits. Proceedings of the National Academy of Sciences of the United States of America 89 (1992) 4806-4810
101. Henley J.M., Ambrosini A., Krogsgaard-Larsen P., and Barnard E.A. Evidence for a single glutamate receptor of the ionotropic kainate/quisqualate type. Nature New Biology 1 (1989) 153-158
102. Herb A., Burnashev N., Werner P., Sakmann B., Wisden W., and Seeburg P.H. The KA-2 subunit of excitatory amino acid receptors shows widespread expression in brain and forms ion channels with distantly related subunits. Neuron 8 (1992) 775-785
103. In: Herrling P. (Ed). Excitatory Amino Acids - Clinical Results with Antagonists (1997), Academic Press, London
104. Hicks T.P., Hall J.G., and McLennan H. Ranking of the excitatory amino acids by the antagonists glutamic acid diethylester and d-α-amino-adipic acid. Canadian Journal of Physiology and Pharmacology 56 (1978) 901-907
105. Hollmann M., and Heinemann S. Cloned glutamate receptors. Annual Review of Neuroscience 17 (1994) 31-108
106. Hollmann M., O'Shea-Greenfield A., Rogers S., and Heinemann S. Cloning and functional expression of a member of the glutamate receptor family. Nature 343 (1989) 643-648
107. Honey C.R., Miljkovic Z., and MacDonald J.F. Ketamine and phencyclidine cause a voltage-dependent block of responses to l-aspartic acid. Neuroscience Letters 61 (1985) 135-139
108. Honore T., Davies S.N., Drejer J., Fletcher E.J., Jacobsen P., Lodge D., and Nielsen F.E. Quinoxalinediones: potent competitive non-NMDA glutamate receptor antagonists. Science 241 (1988) 701-703
109. Honore T., and Drejer J. Chaotropic agents affect the conformation of quisqualate receptors in rat cortical membranes. Journal of Neurochemistry 51 (1988) 457-461
110. Honore T., Drejer J., Nielsen E.O., and Nielsen M. Non-NMDA glutamate receptor antagonist 3H-CNOX binds with equal affinity to two agonist states of quisqualate receptors. Biochemical Pharmacology 38 (1989) 3207-3212
111. Hoo K., Nutt S., Fletcher E.F., Elliot C., Korczack B., Deverill M., Rampersand V., Fantaske R.P., and Kamboj R.K. Functional expression and pharmacological characterization of the human EAA4 (GluR6) glutamate receptor: a kainate selective channel subunit. Receptors and Channels 2 (1994) 327-337
112. Huettner J.E. Glutamate receptor channels in rat DRG neurons: activation by kainate and quisqualate and blockade of desensitization by Con A. Neuron 5 (1990) 255-266
113. 2+-permeable AMPA receptors by Joro spider toxin in cultured rat hippocampal neurones. Journal of Physiology 496 (1996) 431-437
114. Iino M., Ozawa S., and Tsuzuki K. Permeation of calcium through excitatory amino acid receptor channels in cultured rat hippocampal neurons. Journal of Physiology 424 (1990) 151-165
115. Ikeda K., Nagasawa M., Mori H., Araki K., Sakimura K., Watanabe M., Inoue Y., and Mishina M. Cloning and expression of the e4 subunit of the NMDA receptor channel. FEBS Letters 313 (1992) 34-38
116. Ishii T., Moriyoshi K., Sugihara H., Sakurada K., Kadotani H., Yokoi M., Akazawa C., Shiemoto R., Mizuno N., Masu M., and Nakanishi S. Molecular characterization of the family of the N-methyl-d-aspartate receptor subunits. Journal of Biological Chemistry 268 (1993) 2836-2843
117. Ito I., Tanabe S., Kohda A., and Sugiyama H. Allosteric potentiation of quisqualate receptors by a nootropic drug aniracetam. Journal of Physiology 424 (1990) 533-543
118. Jahr C.E., and Stevens C.F. Glutamate activates multiple single channel conductances in hippocampal neurons. Nature 325 (1987) 522-525
119. Jane D.E., Lodge D., and Collingridge G.L. Kainate receptors: pharmacology, function and therapeutic potential. Neuropharmacology 56 (2009) 90-113
120. Jin R., Clark S., Weeks A.M., Dudman J.T., Gouaux E., and Partin K.M. Mechanism of positive allosteric modulators acting on AMPA receptors. Journal of Neuroscience 25 (2005) 9027-9036
121. Johnson J.W., and Ascher P. Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature 325 (1987) 529-531
122. Johnson J.W., and Ascher P. The NMDSA receptor and its channel. Modulation by magnesium and by glycine. In: Lodge D. (Ed). Excitatory Amino Acids in Health and Disease (1988), John Wiley & Sons, London 143-164
123. Johnston G.A.R. The intraspinal distribution of some depressant amino acids. Journal of Neurochemistry 15 (1968) 1013-1017
124. Johnston G.A.R. Glutamate and aspartate as transmitters in the spinal cord. Advances in Biochemical Psychopharmacology 15 (1976) 175-184
125. Jones M.G., and Lodge D. Comparison of some arthropod toxins and toxin fragments as antagonists of excitatory amino acid induced excitation of rat spinal neurons. European Journal of Pharmacology 204 (1991) 203-209
126. Kamboj R.K., Schoepp D.D., Nutt S., Shekter L., Korczak B., True R.A., Rampersad V., Zimmerman D.M., and Wosnick M.A. Molecular structure and pharmacological characterization of human EAA2, a novel human kainate receptor subunit. Molecular Pharmacology 42 (1992) 10-15
127. Kamboj R.K., Schoepp D.D., Nutt S., Shekter L., Korczak B., True R.A., Rampersad V., Zimmerman D.M., and Wosnick M.A. Molecular cloning, expression and pharmacological characterization of human EAA1, a human kainate receptor. Journal of Neurochemistry 62 (1994) 1-9
128. 2+ influx and EPSP in area CA1 of the rat hippocampus. Journal of Physiology 509 (1998) 833-845
129. Karp S.J., Masu M., Eki T., Ozawa K., and Nakanishi S. Molecular cloning and chromosomal localization of the key subunit of the human N-methyl-d-aspartate receptor. Journal of Biological Chemistry 68 (1993) 3728-3733
130. Kehl S.J., McLennan H., and Collingridge G.L. Effects of folic and kainic acids on synaptic responses of hippocampal neurones. Neuroscience 11 (1984) 111-124
131. Keinanen K., Wisden W., Sommer B., Werner P., Herb A., Kohler M., Takagi T., Sakmann B., and Seeburg P.H. A family of AMPA-selective glutamate receptors. Science 249 (1990) 556-560
132. Kemp J.A., and Leeson P.D. The glycine site of the NMDA receptor-five years on. Trends in Pharmacological Sciences 14 (1993) 20-25
133. Kemp J.A., Foster A.C., Leeson P.D., Priestley T., Tridgett R., Iversen L.L., and Woodruff G.N. 7-Chlorokynurenic acid is a selective antagonist at the glycine modulatory site of the N-methyl-d-aspartate receptor complex. Proceedings of the National Academy of Sciences of the United States of America 85 (1988) 6547-6550
134. Kessler M., Terramani T., Lynch G., and Baudry M. A glycine site associated with N-methyl-d-aspartic acid receptors: characterization and identification of a new class of antagonists. Journal of Neurochemistry 52 (1989) 1319-1328
135. Kleckner N.W., and Dingledine R. Requirement for glycine in activation of NMDA receptors expressed in Xenopus oocytes. Science 241 (1988) 835-837
136. Köhler C., Schwarcz R., and Fuxe K. Hippocampal lesions indicate differences between the excitotoxic properties of acidic amino acids. Brain Research 175 (1979) 366-371
137. Korczak B., Nutt S.L., Fletcher E.J., Hoo K.H., Elliott C.E., Rampersand V., McWhinnie E.A., and Kamboj R.K. cDNA cloning and functional properties of human glutamate receptor EAA3 (GluR5) in homomeric and heteromeric configuration. Receptors and Channels 3 (1995) 41-49
138. Krogsgaard-Larsen P., Honore T., Hansen J.J., Curtis D.R., and Lodge D. New class of glutamte agonist structurally related to ibotenic acid. Nature 284 (1980) 64-66
139. Kumar K.N., Tilakaratne N., Johnson P.S., Allen A.E., and Michaelis E.K. Cloning of cDNA for the glutamate-binding subunit of an NMDA receptor complex. Nature 354 (1991) 70-73
140. Kutsuwada T., Kashiwabuchi N., Mori H., Sakimura K., Kushiya E., Araki K., Meguro H., Masaki H., Kumanishi T., Arakawa M., and Mishina M. Molecular diversity of the NMDA receptor channel. Nature 358 (1992) 36-41
141. Lerma J., Morales M., Vicente M.A., and Herreras O. Glutamate receptors of the kainate type and synaptic transmission. Trends in Neurosciences 20 (1997) 9-12
142. Li H., and Rogawski M.A. GluR5 kainate receptor mediated synaptic transmission in rat basolateral amygdala in vitro. Neuropharmacology 37 (1998) 1279-1286
143. Li P., Wilding T.J., Kim S.J., Calejesan A.A., Huettner J.E., and Zhuo M. Kainate-receptor-mediated sensory synaptic transmission in mammalian spinal cord. Nature 397 (1999) 161-164
144. Lodge D., and Anis N.A. Effects of ketamine and three other short acting anaesthetics on spinal reflexes and inhibitions in the cat. British Journal of Anaesthesia 56 (1984) 1143-1151
145. Lodge D., Anis N.A., Berry S.C., and Burton N.R. Arylcyclohexylamines selectively reduce excitation of mammalian neurones by aspartate-like amino acids. In: Kamenka J.M., Domino E.F., and Geneste P. (Eds). Phencyclidine and Related Arylcyclohexylamines: Present and Future Applications (1983), NPP Books, Ann Arbor 595-616
146. Lodge D., and Berry S.C. Psychotomimetic effects of sigma opiates may be mediated by block of central excitatory synapses utilizing receptors for aspartate-like amino acids. In: Bandler R. (Ed). Modulation of Sensory Motor Activity during Altered Behavioural States (1984), Alan R. Liss, Inc., New York 503-518
147. Lodge D., Bond A., O'Neill M.J., Hicks C.A., and Jones M.G. Stereoselective effects of 2,3-benzodiazepines in vivo: electrophysiology and neuroprotection studies. Neuropharmacology 35 (1996) 1681-1688
148. Lodge D., Davies S.N., Aram J.A., Church J., and Martin D. Sigma opiates and excitatory amino acids. In: Lodge D. (Ed). Excitatory Amino Acids in Health and Disease (1988), John Wiley, London 237-259
149. Lodge, D., Dingledine, R., 2001. Ionotropic glutamate receptors. In: The IUPHAR Compendium of Receptor Characterization and Classification, second ed., pp. 189-194.
150. Lodge D., Headley P.M., and Curtis D.R. Selective antagonism by d-alpha-aminoadipate of amino acid and synaptic excitation of cat spinal neurones. Brain Research 152 (1978) 603-608
151. Lodge D., and Johnston G.A.R. Effect of ketamine on amino acid evoked release of acetylcholine from rat cerebral cortex in vitro. Neuroscience Letters 56 (1985) 371-375
152. Lodge D., Johnston G.A.R., Curtis D.R., and Bornstein J.C. Kainate neurotoxicity and glutamate inactivation. Neuroscience Letters 14 (1979) 343-348
153. Lodge D., and Jones M.G. Evidence for glutamate receptor subtypes from in vivo electrophysiology: studies with HA-966, quinoxalinediones and philanthotoxin. Advances in Experimental Medicine and Biology 268 (1990) 101-108
154. Lodge D., Jones M.G., and Palmer A.J. Excitatory amino acids: new tools for old stories. Canadian Journal of Physiology and Pharmacology 69 (1991) 1123-1128
155. Lodge D., Jones M.G., Palmer A.J., and Zeman S. Electrophysiology of glutamate receptors. In: Schousboe A., Diemer N.H., and Kofod H. (Eds). Drug Research Related to Neuroactive Amino Acids, Alfred Benzon Symposium 32 (1992), Munksgaard, Copenhagen 153-160
156. Logan W.J., and Snyder S.H. Unique high affinity uptake systems for glycine, glutamic and aspartic acids in central nervous tissue of the rat. Nature 234 (1971) 297-299
157. Lomeli H., Mosbacher J., Melcher T., Hoger T., Geiger J.R.P., Kuner T., Monyer H., Higuchi M., Bach A., and Seeburg P.H. Control of kinetic properties of AMPA receptor channels by nuclear RNA editing. Science 266 (1994) 1709-1713
158. Lomeli H., Sprengel R., Laurie D.J., Köhr G., Herb A., Seeburg P.H., and Wisden W. The rat delta-1 and delta-2 subunits extend the excitatory amino acid receptor family. FEBS Letters 315 (1993) 318-322
159. Lomeli H., Wisden W., Kohler M., Keinanen K., Sommer B., and Seeburg P.H. High-affinity kainate and domoate receptors in rat brain. FEBS Letters 307 (1992) 139-143
160. 3H] kainic acid to receptor sites in the rat brain. Molecular Pharmacology 15 (1979) 492-505
161. Long S.K., Smith D.A., Siarey R.J., and Evans R.H. Effect of 6-cyano-2,3-dihydroxy-7-nitro-quinoxaline (CNQX) on dorsal root-, NMDA-, kainate- and quisqualate-mediated depolarization of rat motoneurones in vitro. British Journal of Pharmacology 100 (1990) 850-854
162. Lynch G., Granger R., Ambros-Ingerson J., Davis C.M., Kessler M., and Schehr R. Evidence that a positive modulator of AMPA-type glutamate receptors improves delayed recall in aged humans. Experimental Neurology 145 (1997) 89-92
163. Maragos W.F., Greenamyre J.T., Chu D.C., Penney J.B., and Young A.B. A study of cortical and hippocampal NMDA and PCP receptors following selective cortical and subcortical lesions. Brain Research 538 (1991) 36-45
164. Martin D., and Lodge D. Ketamine acts as a non-competitive N-methyl-d-aspartate antagonist on frog spinal cord in vitro. Neuropharmacology 24 (1985) 999-1003
165. Mathers D.A., and Usherwood P.N. Effects of concanavalin A on junctional and extrajunctional l-glutamate receptors on locust skeletal muscle fibres. Comparative Biochemistry and Physiology, C 59 (1978) 151-155
166. Matsuda K., Kamiya Y., Matsuda S., and Yuzaki M. Cloning and characterization of a novel NMDA receptor subunit NR3B: a dominant subunit that reduces calcium permeability. Molecular Brain Research 100 (2002) 43-52
167. Mayer M.L., and Armstrong N. Structure and function of glutamate receptor ion channels. Annual Review of Physiology 66 (2004) 161-181
168. 2+ of NMDA responses in spinal cord neurones. Nature 309 (1984) 261-263
169. Mayer M.L., Westbrook G.L., and Vyklický Jr. L. Sites of antagonist action on N-methyl-d-aspartic acid receptors studied using fluctuation analysis and a rapid perfusion technique. Journal of Neurophysiology 60 (1988) 645-663
170. McBain C., and Dingledine R. Dual-component miniature excitatory synaptic currents in rat hippocampal CA3 pyramidal neurons. Journal of Neurophysiology 68 (1992) 16-27
171. McCulloch R.M., Johnston G.A.R., Game C.J., and Curtis D.R. The differential sensitivity of spinal interneurones and Renshaw cells to kainate and N-methyl-d-aspartate. Experimental Brain Research 21 (1974) 515-518
172. 3H]glycine binding sites in rat brain by quantitative receptor autoradiography. Neuroscience 35 (1990) 653-668
173. McLennan H. Synaptic Transmission (1963), W.B. Saunders, Co., Philadelphia
174. McLennan H. Receptors for excitatory amino acids in the mammalian central nervous system. Progress in Neurobiology 20 (1983) 251-271
175. McLennan H., Collingridge G.C., and Kehl S.J. Electrophysiological actions of kainate and other amino acids and the structure of their receptors. In: Fuxe K., Roberts P., and Schwarz R. (Eds). Excitotoxins (1984), MacMillan, London 19-32
176. McLennan H., Huffman R.D., and Marshall K.C. Patterns of excitation of thalamic neurones by amino-acids and by acetylcholine. Nature 219 (1968) 387-388
177. McLennan H., and Lodge D. The antagonism of amino acid-induced excitation of spinal neurones in the cat. Brain Research 169 (1979) 83-90
178. Meguro H., Mori H., Araki K., Kushiya E., Kutsuwada T., Yamazaki M., Kumanashi T., Arakawa M., Sakimura K., and Mishina M. Functional characterization of a heteromeric NMDA receptor channel expressed from cloned cDNAs. Nature 357 (1992) 70-74
179. Mereu G., Costa E., Armstrong D.M., and Vicini S. Glutamate receptor subtypes mediate excitatory synaptic currents of dopamine neurons in midbrain slices. Journal of Neuroscience 11 (1991) 1359-1366
180. Monaghan D.T., and Beaton J.A. Quinolinate differentiates between forebrain and cerebellar NMDA receptors. European Journal of Pharmacology 194 (1991) 123-125
181. Monaghan D.T., and Beaton J.A. Pharmacologically-distinct NMDA receptor populations of the cerebellum, medial thalamic nuclei, and forebrain. Molecular Neuropharmacology 2 (1992) 71-75
182. Monaghan D.T., Bridges R.J., and Cotman C.W. The excitatory amino acid receptors: their classes, pharmacology, and distinct properties in the function of the central nervous system. Annual Review of Pharmacology and Toxicology 29 (1989) 365-402
183. Monaghan D.T., and Buller A.L. Anatomical, pharmacological and molecular diversity of native NMDA receptor subtypes. In: Collingridge G.L., and Watkins J.C. (Eds). The NMDA Receptor (1994), Oxford University Press, Oxford 158-176
184. 3H] kainic acid binding sites in rat CNS as determined by autoradiography. Brain Research 252 (1982) 91-100
185. Monaghan D.T., Olverman H.J., Nguyen L., Watkins J.C., and Cotman C.W. Two classes of N-methyl-d-aspartate recognition sites: differential distribution and differential regulation by glycine. Proceedings of the National Academy of Sciences of the United States of America 85 (1988) 9836-9840
186. 3H] AMPA binding sites in rat brain as determined by quantitative autoradiography. Brain Research 324 (1984) 160-164
187. Monyer H., and Seeburg P.H. Constituents involved in glutamate receptor signaling. Hippocampus 3 (1993) 125-129
188. Monyer H., Sprengel R., Schoepfer R., Herb A., Higuchi M., Lomeli H., Burnashev N., Sakmann B., and Seeburg P.H. Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Science 256 (1992) 1217-1221
189. Morita T., Sakimura K., Kushiya E., Yamazaki M., Meguro H., Araki K., Abe T., Mori K.J., and Mishina M. Cloning and functional expression of a DNA encoding the mouse beta 2 subunit of the kainate-selective glutamate receptor channel. Molecular Brain Research 14 (1992) 143-146
190. Moriyoshi K., Masu M., lshii T., Shigemoto R., Mizuno N., and Nakanishi S. Molecular cloning and characterization of the rat NMDA receptor. Nature 354 (1991) 31-37
191. Morris R.G. Synaptic plasticity and learning: selective impairment of learning rats and blockade of long-term potentiation in vivo by the N-methyl-d-aspartate receptor antagonist AP5. Journal of Neuroscience 9 (1989) 3040-3057
192. Murray T.K., Whalley K., Robinson C.S., Ward M.A., Hicks C.A., Lodge D., Vandergriff J.L., Baumbarger P., Siuda E., Gates M., Ogden A.M., Skolnick P., Zimmerman D.M., Nisenbaum E.S., Bleakman D., and O'Neill M.J. LY503430, a novel alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor potentiator with functional, neuroprotective and neurotrophic effects in rodent models of Parkinson's disease. Journal of Pharmacology and Experimental Therapeutics 306 (2003) 752-762
193. 3H]glutamate on hippocampal synaptic membranes: three populations differentially affected by chloride and calcium ions. Journal of Neurochemistry 44 (1985) 1791-1798
194. Nakanishi N., Shneider N.A., and Axel R. A family of glutamate receptor genes: evidence for the formation of heteromultimeric receptors with distinct channel properties. Neuron 5 (1990) 569-581
195. Nakanishi S., and Masu M. Molecular diversity and functions of glutamate receptors. Annual Review of Biophysics and Biomolecular Structure 23 (1994) 319-348
196. Nastuk W.L. The electrical activity of the muscle cell membrane at the neuro-muscular junction. Journal of Cellular and Comparative Physiology 42 (1953) 249-272
197. Nicoletti F., Meek J.L., Iadarola M.J., Chuange D.M., Roth B.L., and Costa E. Coupling of inositol phospholipid metabolism with excitatory amino acid recognition sites in rat hippocampus. Journal of Neurochemistry 46 (1986) 40-46
198. Nowak L., Bregestovski P., Ascher P., Herbet A., and Prochiantz A. Magnesium gates glutamate-activated channels in mouse central neurones. Nature 307 (1984) 462-465
199. O'Brien R.J., and Fischbach G.D. Characterization of excitatory amino acid receptors expressed by embryonic chick motoneurons in vitro. Journal of Neuroscience 11 (1986) 3275-3283
200. 3H]-d-AP5 binding sites in rat brain membranes. Nature 307 (1984) 460-462
201. 3H]l-glutamate. Experimental Brain Research 86 (1991) 652-662
202. Ouardouz M., and Durand J. GYKI 52466 antagonizes glutamate responses but not NMDA and kainate responses in rat abducens motoneurones. Neuroscience Letters 125 (1991) 5-8
203. Ouardouz M., and Durand J. Involvement of AMPA receptors in trigeminal post-synaptic potentials recorded in rat abducens motoneurons in vivo. European Journal of Neuroscience 6 (1994) 1662-1668
204. Palmer A.J., and Lodge D. Cyclothiazide reverses AMPA receptor antagonism of the 2,3-benzodizepine, GYKI 53655. European Journal of Pharmacology 244 (1993) 193-194
205. Parsons C.G., Danysz W., and Quack G. Memantine is a clinically well tolerated N-methyl-d-aspartate (NMDA) receptor antagonist - a review of preclinical data. Neuropharmacology 38 (1999) 735-767
206. Parsons C.G., Stöffler A., and Danysz W. Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system - too little activation is bad, too much is even worse. Neuropharmacology 53 (2007) 699-723
207. Paternain A.V., Morales M., and Lerma J. Selective antagonism of AMPA receptors unmasks kainate receptor-mediated responses in hippocampal neurons. Neuron 14 (1995) 185-189
208. Patneau D.K., and Mayer M.L. Kinetic analysis of interactions between kainate and AMPA: evidence for activation of a single receptor in mouse hippocampal neurons. Neuron 6 (1991) 785-798
209. Patneau D.K., Vyklicky Jr. L., and Mayer M.L. Hippocampal neurons exhibit cyclothiazide-sensitive rapidly desensitizing responses to kainate. Journal of Neuroscience 13 (1993) 3496-3509
210. Pin J.-P., Van Vliet B.J., and Bockaert J. Complex interaction between quisqualate and kainate receptors as revealed by measurement of GABA release from striatal neurons in primary culture. European Journal of Pharmacology 172 (1989) 81-91
211. Pook P., Brugger F., Hawkins N.S., Clark K.C., Watkins J.C., and Evans R.H. A comparison of the actions of agonists and antagonists at non-NMDA receptors of C fibres and motoneurones of the immature rat spinal cord in vitro. British Journal of Pharmacology 108 (1993) 179-184
212. Potier M.-C., Spillantini M.G., and Carter N.P. The human glutamate receptor cDNA GhiRl: cloning, sequencing, expression and localization to chromosome 5. DNA Sequence 2 (1992) 211-218
213. Priestley T., Woodruff G.N., and Kemp J.A. Antagonism of responses to excitatory amino acids on rat cortical neurones by the spider toxin, argiotoxin636. British Journal of Pharmacology 97 (1989) 1315-1323
214. Puckett C., Gomez C.M., Korenberg J.R., Tung H., Meier T.J., Chen X.N., and Hood L. Molecular cloning and chromosomal localization of one of the human glutamate receptor genes. Proceedings of the National Academy of Sciences of the United States of America 88 (1991) 7557-7561
215. Purpura D.P., Girado M., Smith T.G., Callan D.A., and Grundfest H. Structure-activity determinants of pharmacological effects of amino acids and related compounds on central synapses. Journal of Neurochemistry 3 (1959) 238-268
216. Rainnie D.G., Asprodini E.K., and Shinnick-Gallagher P. Excitatory transmission in the basolateral amygdala. Journal of Neurophysiology 66 (1991) 986-998
217. Rammes G., Parsons C., Müller W., and Swandulla D. Modulation of fast excitatory synaptic transmission by cyclothiazide and GYKI 52466 in the rat hippocampus. Neuroscience Letters 175 (1994) 21-24
218. Rao T.S., Cler J., Emmett M.R., Mick S., Iyengar S., Contreras P.C., and Wood P.L. Ifenprodil and SL 82.0715 antagonize N-methyl-d-aspartate (NMDA)-coupled glycine receptor responses in vivo. European Journal of Pharmacology 168 (1989) 129-131
219. Récasens M., Sassetti I., Nourigat A., Sladeczek F., and Bockaert J. Characterization of subtypes of excitatory amino acid receptors involved in the stimulation of inositol phosphate synthesis in rat brain synaptoneurosomes. European Journal of Pharmacology 141 (1987) 87-93
220. Reynolds I.J., and Miller R.J. Ifenprodil is a novel type of N-methyl-d-aspartate receptor antagonist: interaction with polyamines. Molecular Pharmacology 36 (1989) 758-765
221. 3H]MK801 binding to rat brain N-methyl-d-aspartate receptors. Journal of Neurochemistry 56 (1991) 1731-1740
222. Roberts P.J. The release of amino acids with proposed neurotransmitter function from the cuneate and gracile nuclei of the rat in vivo. Brain Research 67 (1974) 419-428
223. Roberts P.J. Binding studies for the investigation of receptors for l-glutamate and other excitatory amino acids. Glutamate: Transmitter in the Central Nervous System (1981), John Wiley & Sons, Chichester 35-54
224. Rogawski M.A., and Wenk G.L. The neuropharmacological basis for the use of memantine in the treatment of Alzheimer's disease. CNS Drug Reviews 9 (2003) 275-308
225. Sakimura K., Bujo H., Kushiya E., Araki K., Yamazaki M., Yamazaki M., Meguro H., Warashina A., Numa S., and Mishina M. Functional expression from cloned cDNAs of glutamate receptor species responsive to kainate and quisqualate. FEBS Letters 272 (1990) 73-80
226. Sakimura K., Morita T., Kushiya E., and Mishina M. Primary structure and expression of the gamma 2 subunit of the glutamate receptor channel selective for kainate. Neuron 8 (1992) 267-274
227. Salt T.E., and Eaton S.A. Function of non-NMDA receptors and NMDA receptors in synaptic responses to natural somatosensory stimulation in the ventrobasal thalamus. Experimental Brain Research 77 (1989) 646-652
228. Schoepp D.D., and Conn P.J. Metabotropic glutamate receptors in brain function and pathology. Trends in Pharmacological Sciences 14 (1993) 13-20
229. Schoepp D.D., Lodge D., Bleakman D., Leander J.D., Tizzano J.P., Wright R.A., Palmer A.J., Salhoff C.R., and Ornstein P.L. In vitro and in vivo antagonism of AMPA receptor activation by (3S,4aR,6R,8aR)-6-[2-(1(2)H-tetrazole-5-yl)ethyl] decahydroisoquinoline-3-carboxylic acid. Neuropharmacology 34 (1995) 1159-1168
230. Schoepp D.D., Smith C.L., Lodge D., Millar J.D., Leander J.D., Sacaan A.I., and Lunn W.H.W. d,l-(tetrazol-5-yl) glycine: a novel and highly potent NMDA receptor agonist. European Journal of Pharmacology 203 (1991) 237-243
231. Sheardown M.J., Nielsen E.O., Hansen A.J., Jacobsen P., and Honore T. 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a neuro-protectant for cerebral ischemia. Science 247 (1990) 571-574
232. Shinozaki H., and Konishi S. Actions of several anthelmintics and insecticides on rat cortical neurones. Brain Research 24 (1970) 368-371
233. Shinozaki H., and Shibuya I. A new potent excitant, quisqualic acid: effects on crayfish neuromuscular junction. Neuropharmacology 13 (1974) 665-672
234. Sillar K.T., and Roberts A. Unmyelinated cutaneous afferent neurons activate two types of excitatory amino acid receptor in the spinal cord of Xenopus laevis embryos. Journal of Neuroscience 8 (1988) 1350-1360
235. Simmons R.M., Li D.L., Deverill M., Ornstein P.L., and Iyengar S. Kainate GluR5 receptor subtype mediates the nociceptive response to formalin in the rat. Neuropharmacology 37 (1998) 25-36
236. 3H] kainic acid, and analogue of lglutamate, to brain membranes. Journal of Neurochemistry 26 (1976) 141-147
237. Simon R.P., Swan J.H., Griffiths T., and Meldrum B.S. Blockade of N-methyl-d-aspartate receptors may protect against ischemic damage in the brain. Science 226 (1984) 850-852
238. Sinner B., and Graf B.M. Ketamine. Handbook of Experimental Pharmacology 182 (2008) 313-333
239. Sladeczek F., Pin J.P., Recasens M., Bockaert J., and Weiss S. Glutamate stimulates inositol phosphate formation in striatal neurons. Nature 317 (1985) 717-719
240. Soloviev M.M., Abutidze K., Mellor I., Streit P., Grishin E.V., Usherwood P.N., and Barnard E.A. Plasticity of agonist binding sites in hetero-oligomers of the unitary glutamate receptor subunit XenU1. Journal of Neurochemistry 71 (1998) 991-1001
241. Sommer B., Burnashev N., Verdoorn T.A., Keinanen K., Sakmann B., and Seeburg P.H. A glutamate receptor channel with high affinity for domoate and kainate. EMBO Journal 11 (1992) 1651-1656
242. Sommer B., Keinanen K., Verdoorn T.A., Wisden W., Burnashev N., Herb A., Kohler M., Takagi T., Sakmann B., and Seeburg P.H. Flip and flop: a cell-specific functional switch in glutamate-operated channels of the CNS. Science 249 (1990) 1580-1585
243. Sommer B., Kohler M., Sprengel R., and Seeburg P.H. RNA editing in brain controls a determinant of ion flow in glutamate-gated channels. Cell 67 (1991) 11-19
244. Sprengel R., and Seeburg P.H. The unique properties of glutamate receptor channels. FEBS Letters 325 (1993) 90-94
245. Stanfa L.C., and Dickenson A.H. The role of non-N-methyl-d-aspartate ionotropic glutamate receptors in the spinal transmission of nociception in normal animals and animals with carrageenan inflammation. Neuroscience 93 (1999) 1391-1398
246. Staubli U., Ambros-Ingerson J., and Lynch G. Receptor changes and LTP: an analysis using aniracetam, a drug that reversibly modifies glutamate (AMPA) receptors. Hippocampus 2 (1992) 49-57
247. Stone T.W., and Perkins M.N. Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS. European Journal of Pharmacology 72 (1981) 411-412
248. Sucher N.J., Akbarian S., Chi C.L., Leclerc C.L., Awobuluyi M., Deitcher D.L., Wu M.K., Yuan J.P., Jones E.G., and Lipton S.A. Developmental and regional expression pattern of a novel NMDA receptor-like subunit, NMDAR-L in the rodent brain. Journal of Neuroscience 15 (1995) 6509-6520
249. Sun W., Ferrer-Montiel A.V., Schinder A.F., McPherson J.P., Evans G.A., and Montal M. Molecular cloning, chromosomal mapping, and functional expression of human brain glutamate receptors. Proceedings of the National Academy of Sciences of the United States of America 89 (1992) 1443-1447
250. Takeuchi A., and Takeuchi N. Glutamate-induced depolarization in crustacean muscle. Nature 198 (1963) 490-491
251. Tang C.M., Shi Q.Y., Katchman A., and Lynch G. Modulation of the time course of fats EPSPs and glutamate channel kinetics by aniracetam. Science 254 (1991) 288-290
252. Tarnawa I., Farkas S., Berzsenyi P., Pataki A., and Andrasi F. Electrophysiological studies with 2,3-benzodiazepine muscle relaxant: GYKI 52466. European Journal of Pharmacology 167 (1989) 193-199
253. Turner J.P., and Salt T.E. Characterization of sensory and corticothalamic excitatory inputs to rat thalamocortical neurones in vitro. Journal of Physiology 510 (1998) 829-843
254. Vignes M., and Collingridge G.L. The synaptic activation of kainate receptors. Nature 388 (1997) 179-182
255. Világi I., Kocsis P., Tarnawa I., and Banczerowski-Pelyhe I. Effect of glutamate receptor antagonists on excitatory postsynaptic potentials in striatum. Brain Research Bulletin 46 (1998) 483-486
256. Vyklicky Jr. L., Patneau D.K., and Mayer M.L. Modulation of excitatory synaptic transmission by drugs that reduce desensitization at AMPA/kainate receptors. Neuron 7 (1991) 971-984
257. Ward H.K., and Bradford H.F. Relative activities of glutamine synthetase and glutaminase in mammalian synaptosomes. Journal of Neurochemistry 33 (1979) 339-342
258. Watkins J.C., and Evans R.H. Excitatory amino acid transmitters. Annual Review of Pharmacology and Toxicology 21 (1981) 165-204
259. Watkins J.C., and Olverman H.J. Structural requirements for activation and blockade of EAA receptors. In: Lodge D. (Ed). Excitatory Amino Acids in Health and Disease (1988), John Wiley & Sons, London 13-45
260. Wenthold R.J., Hampson D.R., Wada K., Hunter C., Oberdorfer M.D., and Dechesne C.J. Isolation, localization, and cloning of a kainic acid binding protein from frog brain. Journal of Histochemistry and Cytochemistry 38 (1990) 1717-1723
261. 3H]glutamate binding to hippocampal synaptic membranes: two binding sites discriminated by their differing affinities for quisqualate. Journal of Neurochemistry 41 (1983) 586-593
262. Werner P., Voigt M., Keinanen K., Wisden W., and Seeburg P.H. Cloning of a putative high affinity kainate receptor expressed predominantly in hippocampal CA3 cells. Nature 351 (1991) 742-744
263. Wilding T.J., and Huettner J.E. Differential antagonism of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-preferring and kainate-preferring receptors by 2,3-benzodiazepines. Molecular Pharmacology 47 (1995) 582-587
264. Williams K. Ifenprodil discriminates subtypes of the N-methyl-d-aspartate receptor: polyamine-like and high-affinity antagonist actions. Journal of Pharmacology and Experimental Therapeutics 266 (1993) 231-236
265. Williams K. Interactions of polyamines with ion channels. Biochemical Journal 325 (1997) 289-297
266. Wong E.H.F., and Kemp J.A. Sites for antagonism on the N-methyl-d-aspartate receptor channel complex. Annual Review of Pharmacology and Toxicology 31 (1991) 401-425
267. Wong E.H.F., Kemp J.A., Priestley T., Knight A.R., Woodruff G.N., and Iversen L.L. The anticonvulsant MK-801 is a potent N-methyl-d-aspartate antagonist. Proceedings of the National Academy of Sciences of the United States of America 83 (1986) 7104-7108
268. Wong L.A., and Mayer M.L. Differential modulation by cyclothiazide and concanavalin A of desensitization at native alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid- and kainate-preferring glutamate receptors. Molecular Pharmacology 44 (1993) 504-510
269. Yamamoto C., Sawada S., and Ohno-Shosaku T. Distribution and properties of kainate receptors distinct in the CA3 region of the hippocampus of the guinea pig. Brain Research 783 (1998) 227-235
270. Yamazaki M., Araki K., Shibata A., and Mishina M. Molecular cloning of a cDNA encoding a novel member of the mouse glutamate receptor channel family. Biochemical and Biophysical Research Communications 183 (1992) 886-892
271. Yamazaki M., Mori H., Araki K., Mori K.J., and Mishina M. Cloning, expression and modulation of a mouse NMDA receptor subunit. FEBS Letters 300 (1992) 39-45
272. Yoneda Y., and Ogita K. Heterogeneity of the N-methyl-d-aspartate receptor ionophore complex in rat brain, as revealed by ligand binding techniques. Journal of Pharmacology and Experimental Therapeutics 259 (1991) 86-96
273. Young A.B., and Fagg G.E. Excitatory amino acid receptors in the brain: membrane binding and receptor autoradiographic approaches. Trends in Pharmacological Sciences 11 (1990) 126-133
274. Zarate Jr. C.A., Singh J.B., Carlson P.J., Brutsche N.E., Ameli R., Luckenbaugh D.A., Charney D.S., and Manji H.K. A randomized trial of an N-methyl-d-aspartate antagonist in treatment-resistant major depression. Archives of General Psychiatry 63 (2006) 856-864
275. Zorumski C.F., Yamada K.A., Price M.T., and Olney J.W. A benzodiazepine recognition site associated with the non-NMDA glutamate receptors. Neuron 10 (1993) 61-67
276. Zukin R.S., and Bennett M.V.L. Alternatively spliced isoforms of the NMDAR1 subunit. Trends in Neurosciences 18 (1995) 306-313